CLSTN1 and neoplasm: These functions of CLSTN1 are in part controlled by MAP4 kinases, as P/12k, a neuroprotective, novel selective inhibitor of this kinase family, increased plasma membrane-associated CLSTN1 expression in MB tumor cells and enhanced CLSTN1 localization in tumor-astrocyte interactions.